ArticleCost effectiveness and resource allocation : C/E2014
Cost-effectiveness of eye care services in Zambia.
Article in Cost effectiveness and resource allocation : C/E, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Global prevalence of myopia in children using digital devices: a systematic review and meta-analysis.BMC pediatrics · 2025Pooled it
- Health technology assessment to support health benefits package design: a systematic review of economic evaluation evidence in Zambia.BMC health services research · 2024Pooled it
- Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019Trial
- Change in subjective well-being and the associated costs of a woman-targeted presbyopia correction programme among older craftswomen in Zanzibar: a cost-outcome and scenario analysis.The British journal of ophthalmology · 2025Article
- Economic evaluations in cataract surgery: a narrative review.Eye (London, England) · 2024Review
- Implementing a digital comprehensive myopia prevention and control strategy for children and adolescents in China: a cost-effectiveness analysis.The Lancet regional health. Western Pacific · 2023Article
- Economic Evaluation of Cataract: A Systematic Mapping Review.Ophthalmology and therapy · 2023Review
- Availability of refractive error correction services in selected Zambian hospitals: a cross-sectional quantitative study.BMJ open · 2023Article
- Strategies for cataract and uncorrected refractive error case finding in India: Costs and cost-effectiveness at scale.The Lancet regional health. Southeast Asia · 2022Article
- The Lancet Global Health Commission on Global Eye Health: vision beyond 2020.The Lancet. Global health · 2021Review
- Article
- Health care input constraints and cost effectiveness analysis decision rules.Social science & medicine (1982) · 2018Article
- Infectious disease and health systems modelling for local decision making to control neglected tropical diseases.BMC proceedings · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo estimate the cost-effectiveness of cataract surgery and refractive error/presbyopia correction in Zambia.
methodsPrimary data on costs and health related quality of life were collected in a prospective cohort study of 170 cataract and 113 refractive error/presbyopia patients recruited from three health facilities. Six months later, follow-up data were available from 77 and 41 patients who had received cataract surgery and spectacles, respectively. Costs were determined from patient interviews and micro-costing at the three health facilities. Utility values were gathered by administering the EQ-5D quality of life instrument immediately before and six months after cataract surgery or acquiring spectacles. A probabilistic state-transition model was used to generate cost-effectiveness estimates with uncertainty ranges.
resultsUtility values significantly improved across the patient sample after cataract surgery and acquiring spectacles. Incremental costs per Quality Adjusted Life Years gained were US$ 259 for cataract surgery and US$ 375 for refractive error correction. The probabilities of the incremental cost-effectiveness ratios being below the Zambian gross national income per capita were 95% for both cataract surgery and refractive error correction.
conclusionIn spite of proven cost-effectiveness, severe health system constraints are likely to hamper scaling up of the interventions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.